Rediff Logo
 Money
Line
Channels: Astrology | Broadband | Contests | E-cards | Money | Movies | Romance | Search | Women
Partner Channels: Bill Pay | Health | IT Education | Jobs | Travel
Line
Home > Money > Reuters > Report
September 3, 2001 		Feedback  
  Money Matters

 -  Business Special
 -  Business Headlines
 -  Corporate Headlines
 -  Columns
 -  IPO Center
 -  Message Boards
 -  Mutual Funds
 -  Personal Finance
 -  Stocks
 -  Tutorials
 -  Search rediff

    
      

 
Reuters
 Search the Internet
         Tips
 Sites: Finance, Investment
E-Mail this report to a friend
Print this page

Ranbaxy's unit gets US nod for anxiety drug

A wholly-owned unit of India's top drugmaker by sales, Ranbaxy Laboratories Ltd, has got the US Food and Drug Administration's approval to sell the anxiety drug Lorazepam in the United States, the Bombay Stock Exchange said.

Ranbaxy Pharmaceuticals Inc would immediately launch the drug in the US, the company said in a notice to the exchange at the weekend.

The company also said sales of Lorazepam in 2000 totalled $336.5 million, with the tablet sales alone contributing $270.4 million.

Back to top
(c) Copyright 2000 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Tell us what you think of this report

ADVERTISEMENT